Neuroscientists are urgently seeking new strategies for a causative treatment of Alzheimer’s disease. Yet it is just as important to find reliable procedures to evaluate the likelihood of new treatments succeeding. Researchers have combined two non-invasive imaging techniques, positron emission tomography (PET) and magnetic resonance imaging (MRI), enabling them to examine the proteinaceous deposits typical of Alzheimer’s Disease in transgenic mice.